Form Bio Co. Ltd. (377220) — Capital Reinvestment Ratio

Latest as of September 2022: 3.43x

Form Bio Co. Ltd. (377220) has a Capital Reinvestment Ratio of 3.43x as of September 2022, meaning it reinvests 3% of its operating cash flow (₩3.08 Billion) in capital expenditures (₩10.55 Billion). See net asset quality index of Form Bio Co. Ltd. to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

3.43x
Capex / Operating Cash Flow

Operating Cash Flow

₩3.08 Billion
KRW

Capital Expenditures

₩10.55 Billion
KRW

Data as of

Sep 2022
Most recent filing

Form Bio Co. Ltd. Capital Reinvestment Ratio (2019–2020)

This chart tracks Form Bio Co. Ltd.'s Capital Reinvestment Ratio across 2 annual periods. Check Form Bio Co. Ltd. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Form Bio Co. Ltd. (2019–2020)

Year-by-year Capital Reinvestment Ratio for Form Bio Co. Ltd. from 2019 to 2020. For live market cap and broader valuation context, see 377220 company net worth.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2020 0.42x ₩15.61 Billion ₩6.63 Billion ▲ +5.6%
2019 0.40x ₩5.68 Billion ₩2.28 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow